scholarly journals Hope as a Predictor of Anxiety and Depressive Symptoms Following Pediatric Cancer Diagnosis

2017 ◽  
Vol 43 (2) ◽  
pp. 152-161 ◽  
Author(s):  
Julie N Germann ◽  
David Leonard ◽  
Corey L Heath ◽  
Sunita M Stewart ◽  
Patrick J Leavey
Author(s):  
Juliana Alba-Suarez ◽  
Savannah L. Davidson ◽  
Courtney Priebe ◽  
Puja Patel ◽  
Emily Greenspahn ◽  
...  

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e21547-e21547
Author(s):  
Carolyn Jean Presley ◽  
Arti Hurria ◽  
Ling Han ◽  
Linda S Leo-Summers ◽  
Cary Philip Gross ◽  
...  

e21547 Background: We characterized distinct functional trajectories among older adults in the year before and after a new cancer diagnosis and identified factors associated with functional decline. Methods: Among a cohort study of persons 70+ y, we identified 170 participants (lung (15.7%), breast (12.4%), prostate (7.8%); 31.8% incurable at diagnosis)) with an incident cancer diagnosis from 1998-2014. We followed their functional course using 13 basic, instrumental, and mobility activities measured during monthly interviews. To identify functional trajectories, we fit a group-based trajectory model of the 13-item disability scale 12-months before and 12-months after the cancer diagnosis. Regression modeling determined predictors of functional decline, defined as a higher count on the 13-item disability scale. Results: Three pre-cancer functional trajectories were identified (mean age at diagnosis: 83 y (73-105 y); similarly, 3 post-cancer functional trajectories were identified among the 158 non-decedents. Participants with severe disability pre-diagnosis remained severely disabled post-diagnosis. Approximately 40% of participants with mild or moderate disability pre-diagnosis transitioned to a worse functional trajectory post-diagnosis (see Table). Moderate and severe disability pre-diagnosis were significantly associated with functional decline post-diagnosis (moderate vs. mild aRR: 3.10; 95% CI: 2.24-4.30; severe vs. mild aRR: 5.71; 95% CI: 3.60-9.07). Depressive symptoms (RR, 1.40; 95% CI: 1.02-1.91), and incurable stage (RR, 2.16; 95% CI: 1.54-3.03) were also associated with functional decline. Conclusions: Approximately 40% of older adults experienced functional decline after a new cancer diagnosis. Pre-cancer diagnosis functional trajectory, depressive symptoms, and incurable stage were significant predictors of post-diagnosis functional decline. [Table: see text]


2017 ◽  
Vol 57 (4) ◽  
pp. 330-337
Author(s):  
Mariana Bertoldi Fonseca ◽  
Francisco Hugo Rodrigues Gomes ◽  
Elvis Terci Valera ◽  
Gecilmara Salviato Pileggi ◽  
Paula Braga Gonfiantini ◽  
...  

2013 ◽  
Vol 139 (1) ◽  
pp. 199-206 ◽  
Author(s):  
Nancy E. Avis ◽  
Beverly Levine ◽  
Michelle J. Naughton ◽  
L. Douglas Case ◽  
Elizabeth Naftalis ◽  
...  

2008 ◽  
Vol 30 (11) ◽  
pp. 807-814 ◽  
Author(s):  
Emma Hovén ◽  
Malin Anclair ◽  
Ulf Samuelsson ◽  
Per Kogner ◽  
Krister K. Boman

PEDIATRICS ◽  
2021 ◽  
pp. e2021051696
Author(s):  
Sarah R. Brand McCarthy ◽  
Brenda Schiltz

2018 ◽  
Vol 32 (8) ◽  
pp. 1087-1096 ◽  
Author(s):  
Kemar V. Prussien ◽  
Lexa K. Murphy ◽  
Cynthia A. Gerhardt ◽  
Kathryn Vannatta ◽  
Heather Bemis ◽  
...  

2020 ◽  
Author(s):  
Vincent Israel Opoku Agyapong ◽  
Marianne Hrabok ◽  
Reham Shalaby ◽  
Kelly Mrklas ◽  
Wesley Vuong ◽  
...  

BACKGROUND Cancer diagnoses and treatments usually engender significant anxiety and depressive symptoms in patients, close relatives, and caregivers. Providing psychological support during the coronavirus disease (COVID-19) pandemic presents additional challenges due to self-isolation and social or physical distancing measures in place to limit viral spread. This protocol describes the use of text messaging (Text4Hope-Cancer Care) as a convenient, cost-effective, and accessible population-level mental health intervention. As demonstrated in previous research, this evidence-based program supports good outcomes and high user satisfaction. OBJECTIVE We will implement daily supportive text messaging as a way of reducing and managing anxiety and depression related to cancer diagnosis and treatment in Alberta, Canada. Prevalence of anxiety and depressive symptoms, their demographic correlates, and Text4Hope-Cancer Care–induced changes in anxiety and depression will be evaluated. METHODS Alberta residents with a cancer diagnosis and the close relatives of those dealing with a cancer diagnosis can self-subscribe to the Text4Hope-Cancer Care program by texting “CancerCare” to a dedicated text number. Self-administered, anonymous, online questionnaires will be used to assess anxiety and depressive symptoms using the Hospital Anxiety and Depression Scale (HADS). Data will be collected at onset from individuals receiving text messages, and at the mid- and endpoints of the program (ie, at 6 and 12 weeks, respectively). Data will be analyzed with parametric and nonparametric statistics for primary outcomes (ie, anxiety and depressive symptoms) and usage metrics, including the number of subscribers and user satisfaction. In addition, data mining and machine learning analysis will focus on determining subscriber characteristics that predict high levels of symptoms of mental disorders, and may subsequently predict changes in those measures in response to the Text4Hope-Cancer Care program. RESULTS The first research stage, which was completed in April 2020, involved the creation and review of the supportive text messages and uploading of messages into a web-based text messaging service. The second stage, involving the launch of the Text4Hope-Cancer Care program, occurred in May 2020. CONCLUSIONS Text4Hope-Cancer Care has the potential to provide key information regarding the prevalence rates of anxiety and depressive symptoms in patients diagnosed or receiving care for cancer and their caregivers. The study will generate demographic correlates of anxiety and depression, and outcome data related to this scalable, population-level intervention. Information from this study will be valuable for health care practitioners working in cancer care and may help inform policy and decision making regarding psychological interventions for cancer care. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/20240


Sign in / Sign up

Export Citation Format

Share Document